JFS Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

JFS Wealth Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8K	Buy	+129	New	+$11.6K	﹤0.01%	906

Other funds holding IHE

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

JFS Wealth Advisors's IHE Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 129 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #906 among its holdings.

77 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

JFS Wealth Advisors held 129 shares of iShares US Pharmaceuticals ETF worth $12.8K as of Q2 2026.
iShares US Pharmaceuticals ETF was a new JFS Wealth Advisors position in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #906 holding.
77 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.